MTOR and urinary bladder carcinoma: In bladder cancer, upregulation of ADAMTS9-AS1 was found to be accompanied by activation of the PI3K/AKT/mTOR signaling pathway, whereas downregulation of ADAMTS9-AS1 led to the opposite effect.